Pfizer Inc. announced that its Board of Directors has unanimously appointed Cecile Guegan as Chief Financial Officer and Executive Vice President, effective November 1, 2026. Cecile has served as interim Chief Financial Officer since August 16, 2026, steering the company’s financial operations, execution and strategic…
Curia Global, Inc., a leading contract research, development and manufacturing organization, announced that Philip Macnabb has stepped down as CEO effective as of September 30, 2026. The Company’s search for a new CEO has been underway, and the Company has established the Office of the CEO to oversee the executive tea…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, welcomes Mikey Santiago as its new Chief Information Officer. In this role, Mikey will lead Avantor's global information technology strategy, advancing the company's…
Health In Tech, Inc., an AI-enabled InsurTech platform company transforming the health insurance marketplace through technology, automation and innovation, announced the appointment of Sanjay Shrestha as Chief Executive Officer, effective October 20, 2026. Mr. Shrestha will succeed founder Tim Johnson, who will transi…
WuXi AppTec, a leading global pharmaceutical CRDMO, has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & Sullivan highlighted WuXi AppTec's integrated CRDMO model, which enables the company to support customers across the ful…
Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in adeno-associated virus (AAV) gene therapy manufacturing, a subsidiary of AskBio, Inc. within the Bayer Group, announced that Chief Executive Officer (CEO) Jimmy Vanhove will transition to a new role leading the development a…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner will oversee the company's global finance organizat…
TETRAPHARM has appointed Rolf Sass Sørensen as Chief Executive Officer, effective 6 October 2026. He succeeds Martin Rose, who founded the company together with Jesper Breum in 2018. The leadership transition comes as TETRAPHARM advances its novel drug molecules and proprietary drug development delivery technologies …
Spark Biomedical, a commercial-stage bioelectronic medicine company pioneering non-invasive multi-path neurostimulation devices, announced the addition of three industry veterans who have guided companies to market success. The new team brings the experience to advance Spark's strategic priorities — developing multi-…
Boston Scientific Corporation announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating officer (COO), effective Jan. 1, 2027. In this role, Fitzgerald will oversee the company's global operations, business units and regions. In connection with Fitzgerald's appointment, Boston …
Page 1 of 16